Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 10 - 26    source : Nutriband.com    save search
Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology Conference
Published: 2022-10-26 (Crawled : 12:00) - nutriband.com
NTRB | $3.61 -8.14% -8.86% 22K twitter stocktwits trandingview |
Manufacturing
 | | O: 0.24% H: 10.71% C: -0.95%
SRNE | $0.02 -8.85% 200K twitter stocktwits trandingview |
Health Technology
 | | O: -3.14% H: 10.39% C: 3.25%
conference therapeutics study phase 2b
Gainers vs Losers
75% 25%

Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M twitter stocktwits trandingview |

AGBA | $2.565 105.2% 51.27% 200M twitter stocktwits trandingview |
Finance
MLEC | $2.44 74.29% 42.62% 78M twitter stocktwits trandingview |
n/a
EDBL | News | $6.28 67.02% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.91 48.81% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M twitter stocktwits trandingview |
n/a
VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M twitter stocktwits trandingview |

SDIG A | $3.635 35.13% 26.0% 1M twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.